Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
63
datasets available to search
ShareScore release 0.9.0
Dataset results
63 results for “cabotegravir”
Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa
ClinicalTrials.gov study NCT02462772. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
ClinicalTrials.gov study NCT05996471. IPD Sharing: YES. Countries: 2. Publications: 0.
Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects
ClinicalTrials.gov study NCT02411435. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Effect of High Fat Meal on Cabotegravir
ClinicalTrials.gov study NCT02799264. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.
ClinicalTrials.gov study NCT06643897. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
ClinicalTrials.gov study NCT05835635. IPD Sharing: NO. Countries: 1. Publications: 13.
The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
ClinicalTrials.gov study NCT05515770. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana
ClinicalTrials.gov study NCT05986084. IPD Sharing: YES. Countries: 2. Publications: 0.
Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult
ClinicalTrials.gov study NCT05896748. IPD Sharing: YES. Countries: 6. Publications: 0.
Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males
ClinicalTrials.gov study NCT04692077. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age
ClinicalTrials.gov study NCT05660980. IPD Sharing: YES. Countries: 5. Publications: 0.
A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants
ClinicalTrials.gov study NCT05896761. IPD Sharing: YES. Countries: 7. Publications: 0.
Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants
ClinicalTrials.gov study NCT04371380. IPD Sharing: YES. Countries: 1. Publications: 0.
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
ClinicalTrials.gov study NCT06336434. IPD Sharing: YES. Countries: 2. Publications: 0.
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
ClinicalTrials.gov study NCT07199335. IPD Sharing: YES. Countries: 1. Publications: 0.
Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers
ClinicalTrials.gov study NCT02478463. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1
ClinicalTrials.gov study NCT07275606. IPD Sharing: YES. Countries: 0. Publications: 0.
Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
ClinicalTrials.gov study NCT06485154. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)
ClinicalTrials.gov study NCT06741397. IPD Sharing: YES. Countries: 2. Publications: 0.
Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures
ClinicalTrials.gov study NCT06405464. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.